Hongxia Li

403 total citations
33 papers, 291 citations indexed

About

Hongxia Li is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongxia Li has authored 33 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongxia Li's work include Antimicrobial Resistance in Staphylococcus (4 papers), Extracellular vesicles in disease (4 papers) and Ocular Infections and Treatments (3 papers). Hongxia Li is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Extracellular vesicles in disease (4 papers) and Ocular Infections and Treatments (3 papers). Hongxia Li collaborates with scholars based in China, United States and Japan. Hongxia Li's co-authors include Xiaoyan Liang, Yanli Zou, Yiqiang Wang, Yue Gao, Wengang Song, Xiangyu Meng, Hongbo Zhang, Xiangqun Fang, Yuanyuan Li and Tsugumine Shu and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Hongxia Li

28 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongxia Li China 11 106 77 73 53 42 33 291
David Layfield United Kingdom 8 85 0.8× 70 0.9× 27 0.4× 79 1.5× 95 2.3× 16 380
Sílvia Pérez‐Pujol Spain 11 115 1.1× 42 0.5× 48 0.7× 31 0.6× 36 0.9× 18 429
Marco De Zuani Czechia 13 117 1.1× 199 2.6× 58 0.8× 56 1.1× 31 0.7× 20 419
Koki Ueda Japan 13 210 2.0× 36 0.5× 39 0.5× 74 1.4× 24 0.6× 34 563
Ju Ee Seet Singapore 11 143 1.3× 133 1.7× 70 1.0× 47 0.9× 80 1.9× 32 501
Mixue Xie China 14 91 0.9× 132 1.7× 72 1.0× 152 2.9× 27 0.6× 39 536
Fatemeh Faraji Iran 11 130 1.2× 93 1.2× 13 0.2× 41 0.8× 21 0.5× 31 325
Alexander Zukiwski United States 11 97 0.9× 55 0.7× 72 1.0× 97 1.8× 22 0.5× 26 335

Countries citing papers authored by Hongxia Li

Since Specialization
Citations

This map shows the geographic impact of Hongxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Li more than expected).

Fields of papers citing papers by Hongxia Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Li. The network helps show where Hongxia Li may publish in the future.

Co-authorship network of co-authors of Hongxia Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Li. A scholar is included among the top collaborators of Hongxia Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Li. Hongxia Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongxia, et al.. (2025). The characterization and validation of regulated cell death-related genes in chronic rhinosinusitis with nasal polyps. International Immunopharmacology. 154. 114509–114509.
2.
Liu, Tingting, Bing Liu, Ping Yang, et al.. (2025). Effects of Different Linezolid Concentration Levels on Hematologic Side Effects: A New Target for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring. 47(6). e104–e111.
3.
Liu, Tingting, et al.. (2025). Contezolid for the Super-Elderly: Balancing Efficacy and Safety Through Pharmacokinetic Insights. Clinical Interventions in Aging. Volume 20. 1963–1973.
4.
Liu, Chen, et al.. (2025). circ_0006168 expression serves as a potential biomarker of acquired middle ear cholesteatoma. European Archives of Oto-Rhino-Laryngology. 282(9). 4607–4614.
5.
Liu, Tingting, Yaping Yuan, Chao Wang, et al.. (2024). Therapeutic drug monitoring of linezolid and exploring optimal regimens and a toxicity-related nomogram in elderly patients: a multicentre, prospective, non-interventional study. Journal of Antimicrobial Chemotherapy. 79(8). 1938–1950. 10 indexed citations
6.
Tu, Zhaoxu, Yi Wei, Hongxia Li, et al.. (2024). Functional 2D Nanoplatforms Alleviate Eosinophilic Chronic Rhinosinusitis by Modulating Eosinophil Extracellular Trap Formation. Advanced Science. 11(19). e2307800–e2307800. 13 indexed citations
7.
Hu, Min, et al.. (2022). Identification of DAPK1 as an autophagy-related biomarker for myotonic dystrophy type 1. Frontiers in Genetics. 13. 1022640–1022640. 5 indexed citations
8.
Li, Mengxue, Xiaohong Yang, Abolfazl Masoudi, et al.. (2022). The regulatory strategy of proteins in the mouse kidney during Babesia microti infection. Experimental Parasitology. 235. 108232–108232. 1 indexed citations
9.
Li, Hongxia, Shaofang Zhang, Lin Lin, & Sanjay Rastogi. (2022). Does enteral immune nutrition (EIN) boost the immunity of gastric cancer (GC) patients undergoing surgery? A systematic review and meta-analysis.. Videosurgery and Other Miniinvasive Techniques. 18(1). 31–41. 6 indexed citations
10.
Li, Hongxia, Qin Zhang, Qianqian Duan, et al.. (2022). NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma. Frontiers in Immunology. 13. 894110–894110. 9 indexed citations
11.
Liu, Tingting, et al.. (2021). Early warning of bloodstream infection in elderly patients with circulating microparticles. Annals of Intensive Care. 11(1). 110–110. 2 indexed citations
12.
Liu, Tingting, Jiang Wang, Yanxin Liu, et al.. (2021). Prediction of the Therapeutic Effects of Pembrolizumab and Nivolumab in Advanced Non-Small Cell Lung Cancer by Platelet-Derived Microparticles in Circulating Blood. Technology in Cancer Research & Treatment. 20. 1080265465–1080265465. 9 indexed citations
13.
Liu, Tingting, Jiang Wang, Tao Li, et al.. (2021). Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles. BMC Cancer. 21(1). 939–939. 11 indexed citations
14.
Du, Yingzhen, Pingjun Zhu, Xi Wang, et al.. (2020). Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury. Journal of Autoimmunity. 112. 102464–102464. 33 indexed citations
15.
Ahn, Sarah, Jingjing Li, Chuang Sun, et al.. (2019). Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies. Cancer Immunology Research. 7(5). 773–783. 20 indexed citations
16.
Li, Hongxia, et al.. (2018). Measuring the lactate-to-creatine ratio via 1H NMR spectroscopy can be used to noninvasively evaluate apoptosis in glioma cells after X-ray irradiation. Cellular & Molecular Biology Letters. 23(1). 27–27. 1 indexed citations
17.
18.
Guo, Yinghua, Longxiang Su, Yinghui Li, et al.. (2013). The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Heart and Vessels. 29(4). 520–531. 16 indexed citations
19.
Wang, Yiqiang, Hongbo Zhang, Hongxia Li, et al.. (2011). Th17 cells play a central role in experimental Candida albican keratitis in mice (99.32). The Journal of Immunology. 186(1_Supplement). 99.32–99.32. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Layfield Breakdown of academic impact, for papers by Sílvia Pérez‐Pujol Breakdown of academic impact, for papers by Marco De Zuani Breakdown of academic impact, for papers by Koki Ueda Breakdown of academic impact, for papers by Ju Ee Seet Breakdown of academic impact, for papers by Mixue Xie Breakdown of academic impact, for papers by Fatemeh Faraji Breakdown of academic impact, for papers by Alexander Zukiwski
Rankless by CCL
2026